HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology.

Abstract
Lewy bodies, alpha-synuclein (alpha-syn) immunopositive intracellular deposits, are the pathological hallmark of Parkinson's disease (PD). Interestingly, Lewybody-like structures have been identified in fetal tissue grafts about one decade after transplantation into the striatum of PD patients. One possible explanation for the accelerated deposition of alpha-syn in the graft is that the aggregation of alpha-syn from the host tissue to the graft is spread by a prion disease-like mechanism. We discuss here an in vitro model which might recapitulate some aspects of disease propagation in PD. We found here that in vitro-generated alpha-syn oligomers induce transmembrane seeding of alpha-syn aggregation in a dose- and time-dependent manner. This effect was observed in primary neuronal cultures as well as in neuronal cell lines. The seeding oligomers were characterized by a distinctive lithium dodecyl sulfate-stable oligomer pattern and could be generated in a dynamic process out of pore-forming oligomers. We propose that alpha-syn oligomers form as a dynamic mixture of oligomer types with different properties and that alpha-syn oligomers can be converted into different types depending on the brain milieu conditions. Our data indicate that extracellular alpha-syn oligomers can induce intracellular alpha-syn aggregation, therefore we hypothesize that a similar mechanism might lead to alpha-syn pathology propagation.
AuthorsKarin M Danzer, Simon K Krebs, Michael Wolff, Gerald Birk, Bastian Hengerer
JournalJournal of neurochemistry (J Neurochem) Vol. 111 Issue 1 Pg. 192-203 (Oct 2009) ISSN: 1471-4159 [Electronic] England
PMID19686384 (Publication Type: Journal Article)
Chemical References
  • Intermediate Filament Proteins
  • Peptide Fragments
  • desmuslin
  • Calcium
Topics
  • Animals
  • Calcium (metabolism)
  • Cells, Cultured
  • Cerebral Cortex (cytology)
  • Dose-Response Relationship, Drug
  • Embryo, Mammalian
  • Humans
  • Intermediate Filament Proteins (chemistry, genetics, metabolism, pharmacology)
  • Mice
  • Mutation (genetics)
  • Neuroblastoma (pathology)
  • Neurons (drug effects, metabolism)
  • Peptide Fragments (chemistry, classification)
  • Statistics, Nonparametric
  • Time Factors
  • Transfection (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: